Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia in a Newborn Treated With Remdesivir and Coronavirus Disease 2019 Convalescent Plasma

J Pediatric Infect Dis Soc. 2021 May 28;10(5):691-694. doi: 10.1093/jpids/piaa165.

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel pandemic virus. Mounting evidence supports the possibility of vertical transmission, which at the present time appears to be rare. We report a newborn with vertically acquired SARS-CoV-2 who developed acute respiratory failure and received remdesivir and coronavirus disease 2019 convalescent plasma.

Keywords: COVID-19; SARS-CoV-2; coronavirus; newborn; remdesivir; treatment; vertical transmission.

Publication types

  • Case Reports

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives*
  • Adenosine Monophosphate / therapeutic use
  • Adolescent
  • Alanine / analogs & derivatives*
  • Alanine / therapeutic use
  • Antiviral Agents / therapeutic use*
  • COVID-19 / therapy*
  • COVID-19 / transmission*
  • COVID-19 Serotherapy
  • Female
  • Humans
  • Immunization, Passive
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical*
  • Pneumonia, Viral / therapy*
  • Pneumonia, Viral / transmission*
  • Pneumonia, Viral / virology
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Alanine